The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Nobivac Lepto 2 Suspension for Injection for Dogs



Intervet Ireland LimitedVPA10996/169/001

Main Information

Trade NameNobivac Lepto 2 Suspension for Injection for Dogs
Active SubstancesLeptospira interrogans serogroup Canicola; serovar portland-vere, strain Ca-12-000
Leptospira interrogans serogroup icterohaemorrhagiae strain 820k
Dosage FormSuspension for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/169/001

Group Information

ATC CodeQI07AB01 leptospira
Therapeutic ClassImmunological - Inactivated Vaccine
SpeciesDogs

Status

License statusAuthorised
Licence Issued03/03/2004
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back